{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:26:51Z","timestamp":1774351611534,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate whether abnormal plasma placental growth factor (PlGF) level is associated with adverse neonatal and maternal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This was a secondary analysis of the Preeclampsia Triage by Rapid Assay Trial (PETRA), a prospective, multicenter, observational study that enrolled women with suspected preeclampsia. Our analysis included women age 18\u201345 years with a singleton pregnancy between 20 and 41 weeks of gestation. Plasma collected at enrollment was used for PlGF measurement. Abnormal PlGF was defined as low (100 pg\/mL or less) or very low (less than 12 pg\/mL). The primary outcomes were composite adverse neonatal and maternal outcomes. We used multivariable Poisson regression models to examine the association between PlGF and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 1,112 women who met the inclusion criteria, plasma PlGF was low in 742 (67%) and very low in 353 (32%). In the cohort, the overall rates of the composite adverse neonatal and maternal outcomes were 6.4% and 4.8%, respectively. Compared with normal PlGF (more than 100 pg\/mL), low PlGF was significantly associated with an increased risk of the composite neonatal outcome (9.2% vs 0.8%; adjusted relative risk [aRR] 17.2, 95% CI 5.2\u201356.3), and the composite maternal outcome (6.2% vs 1.9%; aRR 3.6, 95% CI 1.7\u20138.0). Very low PlGF was also significantly associated with both neonatal and maternal outcomes. The sensitivity and specificity of low PlGF were 95.8% and 35.3%, respectively, for the composite neonatal outcome, and 86.8% and 34.3% for the composite maternal outcome. Although the positive predictive values were low (9.2% and 6.2%, respectively), the negative predictive value of low PlGF for neonatal and maternal outcomes was 99.2% and 98.1%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Among women being evaluated for preeclampsia, those with abnormal PlGF are significantly more likely to experience adverse neonatal and maternal outcomes. These outcomes occur infrequently when the PlGF is normal. These findings suggest that PlGF may be useful for risk stratification of women with suspected preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING SOURCE:<\/jats:title>\n                    <jats:p>No funding was received for this study. The original PETRA study was supported by funding from Alere.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000003694","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T18:14:52Z","timestamp":1581012892000},"page":"665-673","source":"Crossref","is-referenced-by-count":33,"title":["Placental Growth Factor and the Risk of Adverse Neonatal and Maternal Outcomes"],"prefix":"10.1097","volume":"135","author":[{"given":"Jacqueline G.","family":"Parchem","sequence":"first","affiliation":[]},{"given":"Clifton O.","family":"Brock","sequence":"additional","affiliation":[]},{"given":"Han-Yang","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Raghu","family":"Kalluri","sequence":"additional","affiliation":[]},{"given":"John R.","family":"Barton","sequence":"additional","affiliation":[]},{"given":"Baha M.","family":"Sibai","sequence":"additional","affiliation":[]},{"name":"for the Preeclampsia Triage by Rapid Assay Trial (PETRA) Investigators","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/AOG.0000000000000965","article-title":"The anachronistic terminology of gestational hypertension: time for a change","volume":"126","author":"Clark","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0002-9378(98)70146-2","article-title":"Prevention of preeclampsia: a big disappointment","volume":"179","author":"Sibai","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"4 suppl","key":"R4-20230711","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"Fisher","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/AOG.0000000000003581","article-title":"Maternal and infant health care costs related to preeclampsia","volume":"134","author":"Hao","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/GRF.0000000000000267","article-title":"Angiogenic and antiangiogenic markers for prediction and risk classification of preeclampsia","volume":"60","author":"Malshe","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2013.01.004","article-title":"Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia","volume":"3","author":"Saffer","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.preghy.2011.08.117","article-title":"A single rapid point-of-care placental growth factor determination as an aid in the diagnosis of preeclampsia","volume":"2","author":"Knudsen","year":"2012","journal-title":"Pregnancy Hypertens"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"67.e1","DOI":"10.1016\/j.ajog.2017.02.037","article-title":"The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study","volume":"217","author":"Romero","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"R17-20230711","first-page":"415","article-title":"Biomarkers for prediction, risk stratification, and ruling out preeclampsia: what are the appropriate goals and objectives?","volume":"34","author":"Barton","year":"2017","journal-title":"Am J Perinatol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/uog.17310","article-title":"Development of pre-eclampsia within 4 weeks of sFlt-1\/PlGF ratio\u2009>\u200938: comparison of performance at 31-34 vs 35-37 weeks' gestation","volume":"49","author":"Dragan","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"R21-20230711","article-title":"Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study","author":"Barton","year":"2019 Sep 10","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20230711","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R23-20230711","first-page":"e1","article-title":"Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 202. American College of Obstetricians and Gynecologists","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/uog.17490","article-title":"Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia","volume":"51","author":"Griffin","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"e50208","DOI":"10.1371\/journal.pone.0050208","article-title":"Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction","volume":"7","author":"Sibiude","year":"2012","journal-title":"PLoS One"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"163.e1","DOI":"10.1016\/j.ajog.2011.09.019","article-title":"Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?","volume":"206","author":"Benton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2393-13-161","article-title":"Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study","volume":"13","author":"Molvarec","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/14767058.2016.1168800","article-title":"PlGF in a clinical setting of pregnancies at risk of preeclampsia and\/or intrauterine growth restriction","volume":"30","author":"Cetin","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.AOG.0000216014.72503.09","article-title":"Circulating angiogenic factors and placental abruption","volume":"108","author":"Signore","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/pd.2143","article-title":"Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation","volume":"28","author":"Poon","year":"2008","journal-title":"Prenat Diagn"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/uog.17229","article-title":"Prediction of stillbirth from placental growth factor at 19-24 weeks","volume":"48","author":"Aupont","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/uog.19017","article-title":"Re: predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia","volume":"51","author":"Kingdom","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1701-2163(16)34983-0","article-title":"Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia integrated estimate of RiSk) study","volume":"33","author":"Yen","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1172\/JCI99026","article-title":"Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice","volume":"128","author":"Parchem","year":"2018","journal-title":"J Clin Invest"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/1471-0528.15855","article-title":"Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis","volume":"126","author":"Duhig","year":"2019","journal-title":"BJOG"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T17:48:11Z","timestamp":1689097691000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003694","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737330711.793579076","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}